Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-10-24
2006-10-24
Shameem, Golam M. M. (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S242000, C544S336000, C544S410000, C546S152000, C546S268100, C546S276400, C514S252100
Reexamination Certificate
active
07125878
ABSTRACT:
The present invention is directed to novel substituted pyrroline compounds useful as kinase inhibitors and methods for treating or ameliorating a kinase mediated disorder.
REFERENCES:
patent: 5057614 (1991-10-01), Davis et al.
patent: 6828327 (2004-12-01), Kuo et al.
patent: 0328026 (1989-02-01), None
patent: WO 95/07910 (1995-03-01), None
patent: WO 00/21927 (2000-04-01), None
patent: WO 00/38675 (2000-07-01), None
Slater et al (1995): STN International CAPLUS database, (Columbus, Ohio), Accession No. 1995:858526.
International Search Report mailed Aug. 25, 2003 for PCT/US03/14113.
Davis, et al., J. Med Chem 1992, 35, 177-194.
Ref. International J. Pharm. 1986, 33, 201-217.
J. Pharm Sci., 1977 (Jan.), 66, 1, 1.
P. Xia, et al., “J. Clin. Invest.”, 1996, 98, 2018.
H. Ishii, et al., “J. Mol. Med.”, 1998, 76, 21.
Inoguchi, et al., “Proc. Natl. Acad. Sci. USA”, 1992, 89, 11059-11065.
Bastyr III, E.J. and Lu, J., “Diabetes”, 1993, 42 (Suppl. 1) 97A.
Hsieh, et al., “Proc. Natl. Acad. Sci. USA”, 1991, 88, 9315-9319.
Hsieh, et al., “J. Biol. Chem.” 1993, 268, 15118-15126.
Murray, et al., “J. Biol. Chem.”, 1993, 268, 15847-15853.
Bilder, G.E. et al., J. Pharmacol. Exp. Ther. 1990, 252, 526-530.
Matsumoto, H. and Sasaki, Y., Biochem. Biophys. Res. Commun., 1989, 158, 105-109.
Yan, S-F, et al, J. boil. Chem., 2000, 275, 16-11921-11928.
Ren, S. et al., Am. J. Physiol. 2000, 278, (4, Pt. 1), E656-E662.
Muid, R.E., et al., FEBS Lett., 1990, 293, 169-172.
Sonoki, H. et al., Kokyo-To Junkan, 1989, 37, 669-674.
Kobayashi, et al., Amer. Phys. Soc. 1994, H1214-H1220.
Toullec, D. et al., J. Biol. Chem 1991, 266, 15771-15781.
Karasik, A., et al., J. Biol. Chem., 1990, 265, 10226-10231.
Chen, K.S., et al. Trans. Assoc. Am. Physicians, 1991, 104, 206-212.
Chin, J.E. et al., J. Biol. Chem., 1993, 268, 6338-6347.
Lee, T-S., et al., J. Clin. Invest., 1989, 83, 90-94.
Lee, T-S., et al., Proc. Natl. Acad. Sci. USA, 1989, 86, 5141-5145.
Craven, PA and DeRubertis, F.R., J. Clin. Invest., 1989, 87, 1667-1675.
Wolf, B.A. et al., J. Clin. Invest., 1991, 87, 31-38.
Tesfamariam, B., et al., J. Clin. Invest., 1991, 87, 1643-1648.
Ishii, H., et al., Science, 1996, 272, 728-731.
X. Gu, et al., Circ. Res., 1994, 75, 926.
R.H. Strasser, et al., Circulation, 1996, 94, 1551.
H. Wakasaki, et al., Proc. Natl. Acad. Sci. USA, 1997, 94, 9320.
Twoemy, B., et al., Biochem. Biophys. Res. Commun., 1990, 191, 1087-1092.
Mulqueen, M.J., et al., Agents Actions, 1992, 37, 85-89.
Nechushtan, H., et al., Blood, 2000 (Mar.), 95, 5, 1752-1757.
Ren, S., et al., A. J. Physiol., 2000, 278, (4, Pt. 1), E656-E662).
Nagpala, P.G., et al, J. Cell Physiol., 1996, 2, 249-55.
Dekker, L.V., et al., Biochem. J., 2000, 347, 285-289.
Slater, J.J., et al., Biorg. & Med. Chem., 1999, 7, 1067-1074.
Rabbi, M.F., et al., Virology, 1998 (Jun. 5), 245, 2, 257-69.
Leitges, M., et al., Science (Wash., D.C.), 1996), 273, 5276, 788-789.
Horn, F., et al., J. Invest. Dermatol., 1987, 88, 220-222.
Raynaud, F. and Evain-Brion, D., Br. J. Dermatol., 1991, 124, 542-546.
Hegemann, L., et al., Arch. Dermatol. Res., 1991, 283, 456-460.
Bollag, W.B., et al., J. Invest. Dermatol., 1993, 100, 240-246.
Rotenberg, S.A. and Weinstein, I.B., Biochem. Mol. Aspects Sel. Cancer, 1991, 1, 25-73.
Ahmad, et al., Molecular Pharmacology, 1993, 43, 858-862.
Meyer, T., et al., Int. J. Cancer, 1989, 43, 851-856.
Akinagaka, S., et al., Cancer Res., 1991, 51, 4888-4892.
Sauma, S., et al., Cell Growth Differ., 1996, 7, 5, 587-94.
Konig, A., et al., Blood, 1997, 90, 10, Suppl. 1 Pt. 2.
Danso, D., et al., Proc. Am. Assoc. Cancer Res., 1997, 38, 88 Meet. 92.
Harrington, E.O., et al., J. Biol. Chem., 1997, 272, 11, 7390-7397.
Begemann, M., et al., Anticancer Res. (Greece), 1998 (Jul.-Aug.), 18, 4A, 2275-82.
Teicher, B.A., et al., Proc. Am. Assoc. Cancer Res., 1998, 39, 89 Meet. 384.
Teicher, B.A., et al., Clinical Cancer Research, 2001 (Mar.), 7, 634-640.
Huang, K.P., Trends Neurosci., 1989, 12, 425-432.
Shimohama, S., et al., Neurology, 1993, 43, 1407-1413.
Hara, H., et al., J. Cereb. Blood Flow Metabl., 1990, 10, 646-653.
Shibata, s., et al., Brain Res., 1992, 594, 290-294.
Beldhuis, H.J.A., et al., Neuroscience, 1993, 55, 4, 965-73.
Miletic, V., et al., Neurosci. Lett., 2000, 288, 3, 199-202.
Chen, C., et al., Science (Wash., D.C.), 1997, 278, 5336, 279-283.
Embi, et al, Eur. J. Biochem, 1980, 107, 519-527.
Cross, et al., Biochemical Journal, 1994, 303, 21-26.
Villar-Palasi C. and Larner J., Biochim. Biophys. Acta, 1960, 39, 171-173.
Parker P.J., et al., Eur. J. Biochem, 1983, 130, 227-234.
Cohen P., Bochem. Soc. Trans. 1993, 21, 555-567.
Srivastava A.K. and Pandey S.K., Mol. and Cellular Biochem., 1998, 182, 135-141.
Chen, et al., Diabetes, 1994, 43, 1234-1241.
Eldar-Finkelman, et al., PNAS, 1996, 93, 10228-10233.
Eldar-Finkelman and Krebs, PNAS, 1997, 94, 9660-9664.
Eldar-Finkelman, et al., Diabetes, 1999, 48, 1662-1666.
Gat, et al., Cell, 1998, 95, 605-614.
Hoeflich K.P., et al., Nature, 2000, 406, 86-90.
Pap and Cooper, J. Biol. Chem., 1998, 273, 19929-19932.
D'Mello, et al., Exp. Cell Res., 1994, 211, 332-338.
Nonaka and Chuang, Neuroreport, 1998, 9(9), 2081-2084.
Hong M. et al., J. Biol. Chem., 1997, 272 (40), 25326-32.
Ikeda, et al., EMBO J., 1998, 17, 1371-1384.
Eastman, Grosschedl, Curr. Opin. Cell Biol., 1999, 11, 233.
Cotter D., et al., Neuroreport, 1998, 9, 1379-1383.
Lijam N., et al., Cell, 1997, 90, 895-905.
Manji, et al., J. Clin. Psychiatry, 1999, 60, (Suppl 2) 27-39.
Jones, R.G.,J. Am. Chem. Soc. 1953, 75, 4048.
Robinson, J. Amer. Chem. Soc., 78, 1956, 1247-1249.
Conway Bruce R.
Demarest Keith
Kuo Gee-Hong
Maryanoff Bruce E.
McComsey David F.
Janssen Pharmaceutica
Shameem Golam M. M.
Stercho Yurity
LandOfFree
Substituted pyrroline kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrroline kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrroline kinase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3636757